Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Measured Wealth Private Client Group LLC

Measured Wealth Private Client Group LLC boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,889 shares of the company’s stock after purchasing an additional 286 shares during the quarter. Measured Wealth Private Client Group LLC’s holdings in Cardinal Health were worth $883,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in CAH. Clearstead Trust LLC acquired a new position in Cardinal Health in the fourth quarter valued at $25,000. Raleigh Capital Management Inc. increased its stake in Cardinal Health by 4,466.7% during the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after acquiring an additional 268 shares during the last quarter. BKM Wealth Management LLC acquired a new stake in Cardinal Health during the fourth quarter worth about $30,000. Hexagon Capital Partners LLC increased its stake in Cardinal Health by 53.6% during the fourth quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock worth $34,000 after acquiring an additional 118 shares during the last quarter. Finally, Wetzel Investment Advisors Inc. acquired a new stake in Cardinal Health during the fourth quarter worth about $36,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Down 1.2 %

NYSE CAH traded down $1.22 on Tuesday, hitting $96.54. 1,822,267 shares of the stock traded hands, compared to its average volume of 2,213,854. The stock has a 50-day moving average of $99.64 and a 200 day moving average of $104.42. Cardinal Health, Inc. has a twelve month low of $85.11 and a twelve month high of $116.04. The company has a market capitalization of $23.51 billion, a P/E ratio of 42.91, a price-to-earnings-growth ratio of 1.11 and a beta of 0.61.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.13. The firm had revenue of $54.90 billion for the quarter, compared to analysts’ expectations of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. Cardinal Health’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 earnings per share. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 2.09%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Monday, July 1st. Cardinal Health’s dividend payout ratio is presently 88.89%.

Analysts Set New Price Targets

Several brokerages have commented on CAH. Wells Fargo & Company dropped their price target on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research note on Monday, April 29th. Robert W. Baird decreased their target price on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research report on Friday, May 3rd. Evercore ISI upped their target price on Cardinal Health from $110.00 to $115.00 and gave the stock an “in-line” rating in a research report on Friday, May 3rd. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Finally, Argus decreased their target price on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $109.67.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.